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Abstract: Three-dimensional (3D) cell cultures allow the mimic of functions of living tissues
and provide key information encoded in tissue architecture. Considered the pivotal role of
epithelial-to-mesenchymal transition (EMT) in carcinoma progression, including prostate cancer
(PCa), we aimed at investigating the effect of the 3D arrangement on the expression of some key
markers of EMT in cultured human prostate cancer (PCa) cells, to better understand PCa cell behavior.
PC3 and DU145 PCa cells were cultured in RPMI cell culture medium either in 2D-monolayers or
in 3D-spheroids. The main EMT markers E-cadherin, N-cadherin, α-smooth muscle actin (αSMA),
vimentin, Snail, Slug, Twist and Zeb1 were evaluated by confocal microscopy, real-time PCR and
Western blot. Confocal microscopy revealed that E-cadherin was similarly expressed at the cell
boundaries on the plasma membrane of PCa cells grown in 2D-monolayers, as well as in 3D-spheroids,
but resulted up-regulated in 3D-spheroids, compared to 2D-monolayers, at the mRNA and protein
level. Moreover, markers of the mesenchymal phenotype were expressed at very low levels in
3D-spheroids, suggesting important differences in the phenotype of PCa cells grown in 3D-spheroids
or in 2D-monolayers. Considered as a whole, our findings contribute to a clarification of the role
of EMT in PCa and confirm that a 3D cell culture model could provide deeper insight into the
understanding of the biology of PCa.
Keywords: epithelial-to-mesenchymal transition; 3D-spheroids; E-cadherin; CD44; prostate cancer
1. Introduction
Prostate cancer (PCa) is a urological disease associated with significant morbidity and mortality,
representing the second most common cause of cancer-related deaths in male population [1].
There are considerable data suggesting that epithelial-to-mesenchymal transition (EMT) plays a
pivotal role in PCa progression [2]. An EMT program is required by cancer cells to acquire functional
characteristics for metastasis, and involves multiple steps including the acquisition of invasiveness,
intravasation in systemic blood or lymphatic systems, subsequent extravasation, and growth at distant
organs [3]. During EMT, cancer cells shed their epithelial features, detach from epithelial sheets, loose
their polarity, and undergo cytoskeletal modifications towards a mesenchymal phenotype, acquiring
a high degree of motility and invasive potential [4]. The EMT-related phenotype is characterized
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by E-cadherin down-regulation, expression of vimentin and α-smooth muscle actin (αSMA), and
secretion of matrix metalloproteinases (MMPs) [4].
Several inducers of EMT acting as transcription factors have been described, such as Snail, Slug,
Twist and Zeb. They repress the expression of E-cadherin and induce the expression of mesenchymal
genes, like vimentin and N-cadherin [5–7]. Repression of E-cadherin expression by EMT transcription
factors was described in vivo and in various cancer cell lines, including lung, breast, colorectal and
ovarian cancer, thus inducing tumor malignancy [8–10].
E-cadherin down-regulation is considered a key event in the EMT process. E-cadherin loss or
decrease at the cell membrane of cancer cells has often been associated with worsening histological
grade and clinical stage, along with poor prognosis in a variety of tumors, including breast, pancreatic,
gastric, and prostate cancer [5,11–14].
However, some heterogeneity in E-cadherin expression has been described in PCa, showing
variable E-cadherin levels in metastatic tissues compared to primary tumor tissues [15–20].
Recently, EMT has been linked to stemness, since cells undergoing EMT acquire stem cell-like
features [21,22]. Stem-like cells acquire a more complete EMT molecular profile, and are reported to
express the cancer stem/progenitor cells marker CD44, which plays an important role in inducing EMT
and/or in maintaining the mesenchymal phenotype in PCa [23,24]. Moreover, both downregulation of
CD44 standard splice isoform (CD44s) and dysregulated splicing were described, leading to increased,
aberrant CD44 variant splice isoforms (CD44v) that play a role in tumor invasion and as prognostic
markers. Both CD44s and CD44v have been linked to the cancer stem cell (CSC) niche and, therefore,
to cancer progression [25,26].
It is generally recognized that cancer cell phenotype can be characterized in vitro in
three-dimensional (3D) cell culture systems, reducing the gap between 2D cell cultures and
physiological tissues. Maintaining a 3D cell arrangement that reflects the in vivo situation in tissue
and tumors in relation to cell-cell interaction and differentiation patterns offers the possibility to better
analyze cancer cell biology and behavior [27–32]. 3D cultures models were also used to investigate
cell-cell interactions in prostate carcinoma cells [33,34].
Since 3D spatial organization addresses the complex interplay of cell-cell interaction and 3D
cultures mimic the 3D structure of living tissue, the aim of this study was to investigate the expression
of the main EMT markers in PCa cell lines (PC3 and DU145), the most common type of human
castration resistant prostate cancer cells employed in experimental in vitro studies, grown in either
2D-monolayers or in 3D-spheroids, in order to better investigate their phenotype and, therefore, their
behavior. Moreover, since EMT has been linked to stem cell phenotype [35–37], we also analyzed the
expression of CD44 isoforms in the same experimental conditions. Our data show that PCa cells grown
in 3D spheroids compared to 2D monolayers are characterized by a different expression of some key
EMT markers and, for the first time to the best of our knowledge, of CD44s and variants, contributing
to new knowledge of the role of EMT markers, particularly E-cadherin, in PCa cell biology.
2. Materials and Methods
2.1. 2D-Monolayer Cell Culture and 3D-Spheroid Preparation
PC3 and DU145 (American Type Culture Collection, ATCC) human castration-resistant prostate
cancer cell lines were cultured in 2D and 3D cell cultures. PC3 and DU145 cell lines were chosen,
since they are the most common and well characterized type of human castration resistant prostate
cancer cells employed in in vitro experimental studies. PC3 and DU145 cells were cultured in RPMI
cell culture medium, supplemented with 7.5% (PC3 cells) or 5% (DU145 cells) heat-inactivated fetal
bovine serum (FBS), 2 mM glutamine, antibiotics (100 U/mL penicillin, 0.1 mg/mL streptomycin), and
cell viability was determined by trypan blue staining. To obtain 3D-spheroids, PCa cells (5 × 104 cells)
were seeded in 24-well multi-well plates coated with 1% agarose in serum-free cell culture medium.
Spheroid integrity was verified by phase-contrast imaging after 3 days, one week and two weeks of
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culture. Since spheroid morphology, integrity, and cell adhesion were not modified starting from day
10 and thereafter, spheroids were harvested after 10 days for morphological and molecular evaluations.
Approximately 300 spheroids were cultured, having a mean 500 µm or 1 mm diameter, respectively,
for DU145 and PC3 3D cell cultures. For molecular analysis, spheroids were pooled and harvested into
two separate pools to obtain duplicate samples of PC3 and DU145. Duplicate samples of the same
cells grown in 2D-monolayers were analyzed when at confluence.
2.2. Immunofluorescence and Confocal Microscopy
For 2D-monolayers analysis, PC3 and DU145 were cultured on 12-mm diameter round coverslips
into 24-well culture plates. When at confluence, cells were washed in phosphate-buffered saline (PBS),
fixed for 10 min at room temperature in 4% paraformaldehyde in PBS containing 2% sucrose, post-fixed
in 70% ethanol and stored at −20 ◦C until use. 3D-spheroids were fixed for 3 h in the same conditions.
3D-spheroids were processed “free-floating” in the wells of 24-well culture plates during fixation and
immunofluorescence procedures. Cells grown in 2D-monolayers and 3D-spheroids were then washed
in PBS three times and incubated for 2 h with the primary antibodies anti-Ki-67 (1:100, Dako, Agilent,
Santa Clara, CA, USA), anti-E-cadherin (1:2500, Becton Dickinson, Milan, Italy), anti-N-cadherin
(1:200, Santa Cruz Biotechnology Inc., Dallas, TX, USA), anti-vimentin (1:200, Novocastra, Leica
Microsystems, Milan, Italy), anti- αSMA (1:400, Sigma-Aldrich, Milan, Italy). Secondary antibodies
conjugated with Alexa 488 (1:500, Molecular Probes, Invitrogen Life Technologies, Monza, Italy) were
applied for 1 h at room temperature in PBS in the dark. Negative controls were incubated omitting
the primary antibody. Finally, cells on coverslips and 3D-spheroids were incubated for 15 min with
4′,6-diamidino-2-phenylindole (DAPI) (1:100.000, Sigma-Aldrich) and mounted onto glass slides using
Mowiol (Sigma-Aldrich).
Sample imaging of PCa cells grown in 2D-monolayers or in 3D-spheroids was performed using
a laser scanning confocal microscope Leica TCS SP8 X (Leica Microsystems GmbH, Mannheim,
Germany). The fluorochromes were excited by a continuous wave 405 nm diode laser and a pulsed
super continuum White Light Laser (470–670 nm; 1 nm tuning step size). DAPI was excited using
diode laser and detected from 409 to 507 nm, AlexaFluor-488 was excited selecting 499 nm-laser line
and detected from 504 to 647 nm. The images were acquired in the scan format 1024 × 1024 pixel
using a HC PL APO 40×/1.30 CS2 oil immersion objective and a pinhole set to 1 Airy unit. Data
were acquired using the Leica LAS X rel. 3.1.1.15751 software (Leica Microsystems GmbH, Mannheim,
Germany).
2.3. Real-Time PCR
Total RNA was isolated by a modification of the acid guanidinium thiocyanate-phenol-chloroform
method (Tri-Reagent, Sigma-Aldrich). For each RNA extraction, approximately 70 3D-spheroids or
3D aggregates and 10–15 × 106 confluent monolayer cells were used. One µg of total RNA was
reverse-transcribed in 20 µL final volume of reaction mix (Bio-Rad, Milan, Italy). mRNA levels for
E-cadherin, N-cadherin, Snail, Slug, Twist, Zeb1, CD44s and variants were assessed. Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) was used as internal control to normalize the differences in the
amount of total RNA in each sample. Primers used for real time PCR are listed in Table 1.
Amplification reactions were conducted in a 96-well plate in a final volume of 20 µL per well,
containing 10 µL of 1× SYBR Green Supermix (Bio-Rad), 2 µL of template, 300 pmol of each primer,
and each sample was analyzed in triplicate in a Bioer LineGene 9600 (Bioer, Hangzhou, China). The
cycle threshold (Ct) was determined and gene expression levels relative to that of GAPDH were
calculated by the 2−∆Ct method.
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Table 1. List of primer used for gene expression analysis.
Gene Primer Forward Primer Reverse
GAPDH CCCTTCATTGACCTCAACTACATG TGGGATTTCCATTGATGACAAGC
E-cadherin GAACGCATTGCCACATACAC GAATTCGGGCTTGTTGTCAT
N-cadherin CCTGAGGGATCAAAGCCTGGAAC TTGGAGCCTGAGACACGATTCTG
Snail CTTCCAGCAGCCCTACGAC CGGTGGGGTTGAGGATCT
Slug TGTTTGCAAGATCTGCGGC TGCAGTCAGGGCAAGAAAAA
Twist AGCAAGATTCAGACCCTCAAGCT CCTGGTAGAGGAAGTCGATGTACCT
Zeb1 GAAAGTCATCCAGCCAAATGG ACTTGGTTCTCAGCTTGGGGAATCA
CD44s GGAGCAGCACTTCAGGAGGTTAC GGAATGTGTCTTGGTCTCTGGTAGC
CD44v2 ATCACCGACAGCACAGACAGAAT AACCATGAAAACCAATCCCAGG
CD44v6 CCAGGCAACTCCTAGTAGTACAACG CGAATGGGAGTCTTCTTTGGGT
CD44v7 GCCTCAGCTCATACCAGCCATC TCCTTCTTCCTGCTTGATGACCT
CD44v9 AGCAGAGTAATTCTCAGAGC TGATGTCAGAGTAGAAGTTGTT
2.4. Western Blot
Cell lysates were prepared in RIPA buffer, incubated on ice for 30 min and centrifuged at 14,000×
g for 15 min at 4 ◦C to remove cell debris. Cell lysates (20 µg of total proteins) were diluted in
sample buffer (Bio-Rad), separated by SDS-PAGE under reducing and denaturing conditions and
transferred onto nitrocellulose membranes. After blocking, membranes were incubated with the
primary antibodies against E-cadherin (1:2500, Becton Dickinson, Milan, Italy), N-cadherin (1:1000,
Cell Signaling Technology Inc., Danvers, MA, USA), Vimentin (1:1000, Leica-Microsystems, Milan,
Italy), Snail (1:1000, Cell Signaling Technology Inc.), Slug (1:1000, Cell Signaling Technology Inc.), Twist
(1:1000, Cell Signaling Technology Inc.) and Zeb1 (1:1000, Cell Signaling Technology Inc.). Detection
was done using horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technology
Inc.) and enhanced chemiluminescence Westar Eta C Ultra 2.0 reagents (Cyanagen, Bologna, Italy).
To confirm equal loading, membranes were reprobed with α-tubulin (1:2000, Sigma-Aldrich).
2.5. Statistical Analysis
Data are expressed as mean ± SD. Comparison between 2D-monolayers and 3D-spheroids
were calculated using independent samples two-tailed t test. p values lower than 0.05 were
considered significant.
3. Results
3.1. 2D-Monolayer and 3D-Spheroid Morphology
PC3 and DU145 PCa cells cultured in 2D-monolayers displayed a polygonal morphology
with tightly apposed cells, consistent with an epithelial phenotype (Figure 1A). When seeded
in agarose-coated wells, PC3 and DU145 PCa cells formed 3D aggregates and 3D-spheroids,
respectively, evident after 40–72 h. 3D cell cultures containing PC3 cells exhibited an irregular
morphology and cells were less densely apposed. In contrast, spheroids containing DU145 cells
had a spheroidal regular morphology and they contained densely packed and strongly adhering cells,
as previously described [33] (Figure 1A). Since PC3 3D-aggregates did not maintain their integrity
during manipulation, immunofluorescence analysis was performed only on DU145 3D-spheroids.
To demonstrate that 3D-spheroids are not just an aggregate of apposed cells, but that they
represent a 3D-cell culture, they were incubated with Ki-67 antibody to detect cell proliferation. Ki-67
protein is a proliferation marker detectable during all active phases of the cell cycle (G(1), S, G(2), and
mitosis), but absent in resting cells (G(0)) [37]. We observed proliferating cells in both 2D-monolayers
and homogeneously throughout 3D-spheroids containing DU145 cells (Figure 1B), confirming that
cells cultured in 3D-spheroids maintain their proliferative phenotype. Moreover, the homogeneous
distribution of proliferative cells in 3D-spheroids allows one to exclude the idea that the eventual
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different expression of EMT markers in different regions of the spheroids is not a consequence of a
different proliferation phenotype.
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Figure 1. Morphology of prostate cancer (PCa) cells grown in 2D-monolayers and 3D cell cultures. 
(A) Micrograph at the inverted microscope showing the epithelial morphology of PC3 and DU145 
cells grown in 2D-monolayers and 3D cell cultures after 10 days. Original magnification: 10×. (B) 
Confocal microscopy showing Ki-67 expression in DU145 grown in 2D-monolayer and 3D-spheroid. 
Original magnification: 40×. Blue: DAPI; green: Ki-67. Bar: 200 µm (A), 20 µm (B). 
3.2. E-Cadherin Expression  
Immunofluorescence analysis revealed that E-cadherin was expressed at cell boundaries in both 
DU145 and PC3 2D-monolayers. A similar expression was observed in DU145 3D-spheroids, 
consistent with the presence of functional adherens junctions, but E-cadherin immunoreactivity was 
more evident in the peripheral region of the spheroids (Figures 2, 3 and S1).  
 
Figure 2. Immunofluorescence analysis of epithelial-to-mesenchymal (EMT) markers in DU145 cells. 
Micrographs using the confocal microscope showing the epithelial marker E-cadherin and 
mesenchymal markers N-cadherin, αSMA and vimentin (green) in DU145 cells grown in 2D-
monolayers and in 3D-spheroids. Original magnification: 40×. Bar: 20 µm. Blue: DAPI. 
i re 1.
( ) Micrograph at he inverted microscope showing the epithelial morphology f PC3 and DU145 cells
grown in 2D-monolayers and 3D cell cultures after 10 days. Original magnification: 10×. (B) Confocal
micros opy sh wing Ki-67 expression in DU145 grown in 2D-monolayer a d 3D-spheroid. Original
magnification: 40×. Blue: DAPI; green: Ki-67. Bar: 200 µm (A), 20 µm (B).
3.2. E-Cadherin Expression
Immunofluorescence analysis revealed that E-cadherin was expressed at cell boundaries in both
DU145 and PC3 2D-monolayers. A similar expression was observed in DU145 3D-spheroids, consistent
with the presence of functional adherens junctions, but E-cadherin immunoreactivity was more evident
in the peripheral region of the spheroids (Figure 2, Figure 3 and Figure S1).
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Figure 4. E-cadherin mRNA and protein levels. Bar graphs showing E-cadherin mRNA levels in PC3 
cells (A) and DU145 cells (B) grown in 2D-monolayers and 3D cell cultures. Data are means ± SD of 
duplicate samples. (C) Representative Western blot analysis showing E-cadherin protein levels in 
whole cell lysates obtained from PC3 and DU145 cells cultured in both experimental conditions. * p < 
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3.3. Expression of Mesenchymal Markers 
. fl l
l markers N-cadherin, αSMA and vimentin (green) in PC3 cells grown in 2D-monolayers.
Origin l magnification: 40×. B r: 20 µm. lue: DAPI.
Gene expression analysis revealed that E-cadherin mRNA levels were expressed at a lower extent
in PC3 and DU145 cells grown in 2D-monolayers compared to 3D-cell cultures, and that E-cadherin
mRNA was up-regulated in PC3 3D aggregates (p ns) and DU145 3D-spheroids (p < 0.05), compared to
2D-monolayers (Figure 4A,B). Western blot analysis confirmed this expression pattern, showing that
the gene expression pattern was concordant with protein levels. In fact, higher levels of full-length
E-cadherin (120 KDa) were detectable in PC3 compared to DU145 2D-monolayers, and they were
strongly up-regulated in 3D cell cultures compared to 2D-monolayers in both cell lines (Figure 4C).
The analysis of the electrophoretic pattern also showed E-cadherin degradation fragments in both PC3
and DU145 2D-monolayers, consistent with cell junction disruption and, as a consequence, lower cell
adhesion. A main fragment having an 80 kDa olecular weight was detected. These fragments were
undetectable in cells grown in 3D-spheroids and 3D aggregates (Figure 4C).
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Figure 4. E-cadherin mRNA and protein levels. Bar graphs showing E-cadherin mRNA levels in PC3
cells (A) and DU145 cells (B) grown in 2D-monolayers and 3D cell cultures. Data are means ± SD
of duplicate samples. (C) Representative Western blot analysis showing E-cadherin protein levels
in whole cell lysates obtained from PC3 and DU145 cells cultured in both experimental conditions.
* p < 0.05 vs DU145 2D-monolayer.
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3.3. Expression of Mesenchymal Markers
Using immunofluorescence, we analyzed the expression of key EMT markers related to the
acquisition of a mesenchymal phenotype. Confocal microscopy of 2D-monolayers revealed that
N-cadherin was almost undetectable or expressed at very low levels in DU145 and PC3, respectively,
showing that this mesenchymal marker is not detectable using a 2D cell culture. A different pattern of
expression was observed for αSMA and vimentin immunoreactivity, that was strongly expressed in
both cell lines (Figures 2 and 3). The analysis of DU145 3D-spheroids showed that these mesenchymal
markers were differentially expressed, other than αSMA, which was not influenced by 3D arrangement
and therefore was evaluated only at the morphological level. Indeed, in DU145 cells grown in
3D-spheroids N-cadherin was detected in some few scattered cells, mostly located in the central
region of the spheroid. Vimentin was expressed in all cells, although its immunoreactivity was more
evident in the central region of the spheroids, similar to N-cadherin expression (Figure 2). Notably, the
expression of vimentin and N-cadherin markers was more intense in the deep portion of the spheroids,
while E-cadherin exhibited the opposite pattern of expression and was more intensely expressed in the
outer region.
The expression of mesenchymal markers was also analyzed at the mRNA and protein level.
According to the morphological analysis, N-cadherin gene expression was higher in PC3 cells while it
was very low in DU145 cells cultured in 2D-monolayers (Figure 5A). While its expression was similar
in DU145 cultures in 2D and 3D, N-cadherin gene expression was stimulated by 3D arrangement in
PC3 cells (Figure 5A). Vimentin showed the opposite gene expression pattern, since it was similar in
2D and 3D cell cultures in PC3 cells, while expressed at a lower extent in DU145 3D compared to 2D
cell cultures (Figure 5C). Since mRNA levels are not predictive of protein levels, due to translational
and posttranslational regulations, N-cadherin and vimentin protein levels were analyzed. Higher
N-cadherin protein levels were detected in PC3 3D-spheroids, consistent with gene expression, while
they were undetectable in 2D and 3D cell cultures containing DU145 cells (Figure 5B). Vimentin protein
levels were expressed at a lower extent in DU145 cells, similarly to mRNA, compared to PC3 cells.
However, in both cell lines, vimentin was downregulated by 3D arrangement (Figure 5D).
Cells 2019, 8, 143 7 of 17 
7 
 
Using immunofluorescence, we analyzed the expression of key EMT markers related to the 
acquisition of a mesenchymal phenotype. Confocal microscopy of 2D-monolayers reveale  that N-
cadherin was al ost undetectable or expressed at very low levels in U145 and PC3, respectively, 
showing that this mesenchymal marker is not detectable using a 2D cell culture. A different pattern 
of expression was observed for αSMA and vimentin immunoreactivity, that was strongly expressed 
in both cell lines (Figures 2 and 3). The analysis of DU145 3D-spheroids showed that these 
mesenchymal markers were differentially expressed, other than αSMA, whic  was not influenced by 
3D arrangement and therefore was evaluated only at the morphological level. Indeed, in DU145 cells 
grown in 3D-spheroids N-cadherin was detected in some few scattered cells, mostly located i  the 
central region of the spheroid. Vimentin was expressed in all cells, although its immunoreactivity 
was more evident in the central region of the spheroids, similar to N-cadheri  expression (Figure 2). 
Notably, t e expression of vimentin and N-cadherin markers was more intense in the deep portion 
of the spheroids, while E-cadherin exhibited the opposite pattern of ex ression and was more 
intensely expressed in the outer region. 
The expression of mesenchymal markers was also analyzed at the mRNA and protein level. 
According to the morphological an lysis, N-cadherin gene expression was higher in PC3 cells while 
it was very low in DU145 cells cultured in 2D-monolayers (Figure 5A). While its expression was 
similar in DU145 cultures in 2D a d 3D, N-cadherin gene expression was stimulated by 3D 
arrangement in PC3 cells (Figure 5A). Vimenti  show d the opposite gen  expression pattern, since 
it was similar in 2D and 3D cell cultures in PC3 cells, whil  expressed t a lower extent in DU145 3D 
compared to 2D cell cultures (Figure 5C). Since mRNA levels are not predictive of pr tein l vels, due 
to translational and posttranslational r gulations, N-cadherin and vimentin protein levels were 
analyzed. Higher N-cadherin protein levels were etect d i  PC3 3D-spheroids, co sistent with gene 
expression, while they were undetectable in 2D and 3D cell cultures containing DU145 cells (Figure 
5B). Vime tin protein levels were expressed at a lower extent in DU145 cells, similarly to mRNA, 
compared to PC3 c lls. However, in both cell lines, vimentin was downregulated by 3D arrangement 
(Figur  5D). 
 
Figure 5. N-cadherin and vimentin mRNA and protein levels. Bar graphs showing N-cadherin (A) 
and vimentin (B) mRNA levels in PC3 and DU145 cells grown in 2D-monolayers and 3D cell cultures. 
Data are means ± SD of duplicate samples. Representative Western blot analysis showing N-cadherin 
(C) and vimentin (D) protein levels in whole cell lysates obtained from PC3 and DU145 cells cultured 
in both experimental conditions. 
Among EMT markers, EMT transcriptional regulators Snail, Slug, Twist, and Zeb1 play a key 
role. We analyzed their expression at the mRNA and protein levels, as shown in  Figures 6 and 7. 
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and vimentin (D) protein levels in whole cell lysates obtained from PC3 and DU145 cells cultured in
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Among EMT markers, EMT transcriptional regulators Snail, Slug, Twist, and Zeb1 play a key
role. We analyzed their expression at the mRNA and protein levels, as shown in Figures 6 and 7.
Snail mRNA levels were similarly expressed in PC3 and DU145 2D-monolayers and 3D cell cultures
(Figure 6A,E). Slug and Twist were expressed at a higher extent in PC3 compared to DU145 cells
(Figure 6B,C,F,G), and they tended to increase in 3D-cell cultures, showing a significant up-regulation
in PC3 3D-spheroids compared to 2D-monolayers (p < 0.05) (Figure 6B,C). Similar Zeb1 mRNA were
detected in PC3 and DU145 cells, resulting in significantly increased PC3 3D aggregates compared to
2D-monolayers (p < 0.05) (Figure 6D,H). Gene expression was not confirmed by Western blot analysis,
revealing that these EMT markers undergo important translational and posttranslational regulation.
In fact, Snail, Slug, Twist, and Zeb1 were strongly down-regulated in 3D cell cultures compared to
2D-monolayers (Figure 7). Interestingly, low or undetectable expression of these EMT markers was
consistent with the high expression of E-cadherin under both experimental conditions.
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3.4. CD44 Gene Expression
Gene expression for CD44s and CD44 v2, v6, v7, and v9 variants was investigated by real-time
PCR, showing that they are expressed at a higher extent in PC3 compared to DU145 cells. If we analyzed
the effect of 3D arrangement, CD44s and variants were up-regulated in PC3 3D-spheroids compared
to 2D-monolayers (Figure 8). The difference was statistically significant for CD44s, v2, v6, v7 (p < 0.05)
(Figure 8A–D). CD44s and CD44 variants were expressed in DU145 cells at a lower extent, compared
to PC3 cells, but only CD44s gene expression was affected by 3D arrangement, despite undergoing an
opposite regulation compared to PC3 cells. In fact, CD44s was significantly down-regulated in DU145
spheroids compared to 2D-monolayers (p < 0.05) (Figure 8A), whilst CD44 isoform expression was not
influenced by 3D arrangement (Figure 8B–E). To understand the functional role of CD44s and variant
expression, the CD44s to CD44v ratio could be calculated. CD44s/v2 was highly expressed in PC3 and
DU145 2D-monolayers, and tended to decrease in 3D cell cultures (p = 0.054 for DU145 cells) (Figure 9).
CD44s/v6, CD44s/v7 and CD44/v9 were nor significantly affected by 3D arrangement in PC3 cells.
By contrast, they were down-regulated in DU145 3D-spheroids (p < 0.05, p ns, p < 0.05, respectively)
(Figure 9).
Cells 2019, 8, 143 9 of 17 
9 
 
ene expression for 44s and 44 v2, v6, v7, and v9 variants as investigated by real-ti e 
P R, showing that they are expressed at a higher extent in PC3 compared to DU145 cells. If we 
analyzed the effect of 3D arrangement, CD44s and variants were up-regulated in PC3 3D-spheroids 
compared to 2D-monolayers (Figure 8). The difference was statistically significant for CD44s, v2, v6, 
v7 (p < 0.05) (Figure 8A–D). C 44s and CD44 variants were expressed in DU145 cells at a lower extent, 
compared to PC3 cells, but only CD44s gene expression was affected by 3D arrangement, despite 
undergoing an opposite regulation compared to PC3 cells. In fact, CD44s was significantly down-
regulated in DU145 spheroids compared to 2D-monolayers (p < 0.05) (Figure 8A), whilst CD44 
isoform expression was not influenced by 3D arrangement (Figure 8B–E). To understand the 
functional role of CD44s and variant expression, the CD44s to CD44v ratio could be calculated. 
CD44s/v2 was highly expressed in PC3 and DU145 2D-monolayers, and tended to decrease in 3D cell 
cultures (p = 0.054 for DU145 cells) (Figure 9). CD44s/v6, CD44s/v7 and CD44/v9 were nor 
significantly affected by 3D arrangement in PC3 cells. By contrast, they were down-regulated in 
DU145 3D-spheroids (p < 0.05, p ns, p < 0.05, respectively) (Figure 9).  
 
Figure 8. CD44s and variants gene expression. Bar graphs showing CD44s (A), CD44v2 (B), CD44v6 
(C), CD44v7 (D) and CD44v9 (E) gene expression in PC3 and DU145 cells grown in 2D-monolayers 
and 3D cell cultures. Data are means ± SD of duplicate samples. * p < 0.05 vs 2D-monolayer. 
 
Figure 9. CD44s/CD44 variant in PC3 and DU145 cells. Bar graphs showing the CD44s/CD44 variant 
in PC3 and DU145 cells grown in 2D-monolayers and 3D cell cultures. Data are means ± SD of 
duplicate samples. * p < 0.05 vs 2D-monolayer. 
4. Discussion 
Figure 8. CD44s and variants gene expression. Bar graphs showing CD44s (A), CD44v2 (B), CD44v6
(C), CD44v7 (D) and CD44v9 (E) gene expression in PC3 and DU145 cells grown in 2D-monolayers
and 3D cell cultures. Data are means ± SD of duplicate samples. * p < 0.05 vs 2D-monolayer.
Cells 2019, 8, 143 9 of 17 
9 
 
Gene expression f r CD44s and CD44 v2, v6, v7, and v9 variants was investigated by real-time 
PCR, showing that they are expressed at a higher extent in PC3 compared to DU145 cells. If we 
analyzed the effect of 3D arrangement, CD44s and variants were up-regulated in PC3 3D-spheroids 
compared to 2D-monolayers (Figure 8). The difference was statistically significant for C 44s, v2, v6, 
v7 (p < 0.05) (Figure 8A–D). CD44s and CD44 variants were expressed in DU145 cells at a lower extent, 
compared to PC3 cells, but only CD44s gene expression was affected by 3D arrangement, despite 
undergoing an opposite regulation compared to PC3 cells. In fact, CD44s was significantly down-
regulated in DU145 spheroids compared to 2D-monolayers (p < 0.05) (Figure 8A), whilst CD44 
isoform expression was not influenced by 3  arrangement (Figure 8B–E). To understand the 
functional role of CD44s and variant expression, the CD44s to CD44v ratio could be calculated. 
CD44s/v2 was highly expressed in PC3 and DU145 2D-monolayers, and tended to decrease in 3D cell 
cultures (p = 0.054 for DU145 cells) (Figure 9). CD44s/v6, CD44s/v7 and CD44/v9 were nor 
significantly affected by 3D arrangement in PC3 cells. By contrast, they were down-regulated in 
DU145 3D-spheroids (p < 0.05, p ns, p < 0.05, respectively) (Figure 9).  
 
Figure 8. CD44s and variants gene expression. Bar graphs showing CD44s (A), CD44v2 (B), CD44v6
(C), CD44v7 (D) and CD44v9 (E) gene xpression in PC3 and DU145 cells grown in 2D-monolayers 
and 3  cell cultures. Data are means ± SD of duplicate samples. * p < 0.05 vs 2D-monolayer. 
 
Figure 9. CD44s/CD44 variant in PC3 and DU145 cells. Bar graphs showing the CD44s/CD44 variant 
in PC3 and DU145 cells grown in 2D-monolayers and 3D cell cultures. Data are means ± SD of 
duplicate samples. * p < 0.05 vs 2D-monolayer. 
4. Discussion 
Figure 9. CD44s/CD44 variant in PC3 and DU145 cells. Bar graphs showing the CD44s/CD44 variant
in PC3 and DU145 cells grown in 2D-monolayers and 3D cell cultures. Data are means ± SD of
duplicate samples. * p < 0.05 vs 2D-monolayer.
Cells 2019, 8, 143 10 of 17
4. Discussion
The loss of epithelial phenotype and cell-cell adhesion driven by the down-regulation of
E-cadherin, a well characterized transmembrane protein of adherens cell junctions expressed in
differentiated and polarized epithelial cells, is the key early event during EMT, and it is considered
an essential prerequisite for carcinoma progression to metastatic disease [4]. However, tumors are
heterogeneous and cancer cells may undergo only a partial transition that enhances invasion, while
still retaining certain epithelial characteristics such as E-cadherin expression, leading to the observation
of cells displaying an “intermediate” phenotype. Indeed, E-cadherin loss does not always correlate
with invasion [38].
Some heterogeneity in E-cadherin expression has been previously described in pancreatic
adenocarcinoma [31,39] as well as in PCa, showing variable E-cadherin expression in metastatic
tissues compared to primary tumor tissues [15–20], thus increasing the relevance of studies aimed at
characterizing the phenotype of PCa cells in relation to the expression of EMT markers, and especially
of E-cadherin, in order to better understand PCa development and progression.
Since E-cadherin is considered a pivotal determinant in the EMT mechanism [4,5], we analyzed
this EMT “epithelial” marker at the morphological and molecular level. Immunofluorescence analyses
show that both PC3 and DU145 cells grown in 2D-monolayers are characterized by an intense
E-cadherin immunoreactivity at the cell-cell boundary, suggesting that PC3 and DU145 cells have an
epithelial phenotype. A similar E-cadherin immunoreactivity was detected in DU145 3D-spheroids,
suggesting that the adherent junctions are retained by PCa cells under both experimental conditions.
Gene expression analysis showed that E-cadherin mRNA levels tend to increase in PC3 cells and are
significantly up-regulated in DU145 cells grown in 3D cell cultures. Since this pattern of expression
parallels E-cadherin protein levels, cells grown in 3D-spheroids may have stronger cell adhesion,
pointing to a possible transcriptional regulation of E-cadherin level in PCa cells. The significant
up-regulation of E-cadherin mRNA levels in DU145 3D-spheroids compared to 2D-monolayers is
consistent with the observation of more compact spheroids compared to PC3 cells, forming more
irregular and loose cell aggregates, as previously described [33]. The analysis of the E-cadherin
electrophoretic pattern revealed protein fragments detectable only in 2D-monolayer cell lysates,
indicating a post-translational modification of this protein mediated by proteolytic cleavage. Partial
E-cadherin degradation in PCa cells grown in 2D-monolayers could likely induce a reduced cell-cell
adhesion, compared to cells grown in 3D-spheroids.
E-cadherin cleavage has been linked to the malignant progression of adenocarcinomas, including
prostate cancer [40,41]. We observed 80, 65, and 55 kDa cleavage fragments of E-cadherin. The 80 kDa
fragment was detected in the media of mouse and human mammary tumor cells [42] and described in
prostate cancer patients [43].
The degradation and functional loss of E-cadherin are described as key molecular alterations that
occur during tumor progression and are mediated by a variety of mechanisms, including transcriptional
repression, epigenetic silencing, inactivating mutation, enhanced degradation, endocytosis, and
proteolytic cleavage [44,45]. The 80 kDa proteolytic fragment could be generated by MMP activity in
cell culture systems [46,47], pointing to the involvement of MMP in proteolytic cleavage events leading
to E-cadherin inactivation and resulting in the disruption of cell-cell adhesion and the promotion of
the malignant progression of prostate epithelial cells.
Here we show that full length E-cadherin is up-regulated in 3D-spheroids. A similar situation was
previously described in pancreatic adenocarcinoma cells [31], indicating a stronger cohesion by linking
cells together and ensuring tissue integrity during collective cell migration [48]. This hypothesis is
supported by the observation that the more intense E-cadherin immunoreactivity is evident at the
periphery of 3D-spheroids corresponding to the leading edge of migrating epithelial sheets where the
front cells retain intact cell–cell junctions to mechanically hold the cells together [49].
During EMT the “cadherin switch” is described, leading to the expression of N-cadherin, the
transmembrane protein of adherens junctions in mesenchymal cells. Our data show that N-cadherin
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immunoreactivity was almost undetectable in DU145 and PC3 2D-monolayers, and seemed more
evident in DU145 3D-spheroids. In fact, some few scattered cells expressing N-cadherin were detected
in DU145 3D-spheroids, that, interestingly, were located in the central region of the spheroid where
E-cadherin is less evident. This observation confirms that a cadherin switch occurred in PCa cells, and
that this is more evident in PCa cells grown in 3D-spheroids. The expression of N-cadherin confirms
the EMT-related phenotype of PCa cells. However, N-cadherin is less effective in forming cell junctions
compared to E-cadherin, and its higher expression in PC3 cells is consistent with a “more mesenchymal
phenotype” of these cells, compared to DU145, and with the irregular morphology of PC3 spheroids.
The molecular analysis of N-cadherin in PC3 suggests that N-cadherin gene and protein expression
is affected by 3D-spheroids, showing a higher expression of this EMT marker. The mesenchymal
markers αSMA and vimentin were strongly expressed in PC3 and DU145 cells grown either in 2D or
3D cell cultures. Interestingly, vimentin immunoreactivity was more evident in the central region of
DU145 spheroids, similarly to N-cadherin, where E-cadherin is less evident. Conversely, E-cadherin
immunoreactivity is more intense in the outer region of 3D-spheroids, offering a higher cell adhesion.
This finding seems to confirm the hypothesis that peripheral cells in PCa 3D-spheroids exhibit the
properties of a leading edge invading surrounding tissues, where a more evident epithelial phenotype
is functional to favor a collective migration and invasion of cancer cells. Tumors might utilize this
particular strategy of migration to permit the movement of carcinoma cells that have not lost their
well-differentiated epithelial morphology.
E-cadherin expression can be regulated through a combination of genetic, epigenetic,
transcriptional and post-transcriptional mechanisms. Zinc finger family members Snail and Slug,
the basic helix-loop-helix factor Twist, and the handed zinc factors Zeb1 act as major transcriptional
repressors of E-cadherin [50].
Snail can be considered as one of the master EMT regulators and is a promoter of metastasis
by inducing the expression of mesenchymal markers. Snail has also been implicated in cancer
cell survival, cell cycle regulation, apoptosis evasion, cell adhesion, neuroendocrine differentiation,
and chemoresistance [50–52]. A correlation between high Snail expression in tumors and tumor
aggressiveness and poor prognosis was described [12,53,54], and Snail overexpression was detected in
several cancer cells including PCa, where it has been suggested that it is up-regulated at early stages of
PCa development [55].
Our results confirm the association of low E-cadherin with high Snail in cells grown in
2D-monolayers, showing a strong down-regulation of Snail in 3D-spheroids, paralleled by the increased
E-cadherin expression.
Although Slug, Twist, and Zeb1 mRNA levels were significantly up-regulated in PC3 3D-spheroids,
Slug, Twist and Zeb1 protein levels resulted strongly decreased, suggesting that their expression is likely
dependent on mRNA stability, translational regulation, or posttranslational modification.
Our results show that 3D arrangement affects PCa cell phenotype, especially in PC3 cells, and that
PC3 and DU145 concomitantly express epithelial and mesenchymal markers having an intermediate
phenotype. The expression of E-cadherin in PCa was previously investigated as a possible reliable
marker for PCa. Its aberrant expression was detected, since loss of E-cadherin membrane staining was
present in 14% of the morphologically normal prostates, more frequent in localized cancer samples
(44% of cases), but not in metastasis (6% and 7% of cases) [56]. This is an interesting finding, pointing
to an early and transient E-cadherin down-regulation favoring the detachment of cancer cells from
the primary tumor, while metastatic cells retain high E-cadherin expression to favor their collective
migration for tumor dissemination [19,57]. The concomitant cell-cell adhesion and expression of
mesenchymal markers in PCa cells is a key feature of collective cell migration, and the possession of a
partial EMT phenotype may be advantageous for metastatic progression by favoring both metastasis
and metastatic recolonization [58].
According to this suggestion, we can hypothesize that transcription factors involved in EMT
could be differently expressed in different moments during PCa progression, and the prognostic value
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of EMT markers should be carefully evaluated during cancer progression. However, the relationships
between EMT transcription factors and target genes such as E-cadherin are likely to be more complex
in vivo than those identified in cultured cells. A comparison of biological properties and behavior
of PCa cells cultured in 2D-monolayers or 3D-spheroids was previously described by [34] on 29
prostate cancer cell lines, including PC3 and DU145 cells. That study described spheroid morphology
and behavior, especially in relation to EMT and spheroid invasive potential. However, the results,
although showing differences in 2D and 3D cell cultures, are not comparable with our data. In fact,
3D-spheroids were cultured in different experimental conditions using Matrigel, representing an
important stimulus-inducing differentiation program different than in cells cultured without any
interaction with ECM components.
Cells undergoing EMT express biomarkers such as CD44, recognized as a cancer stem cell marker.
CD44 is a widely expressed adhesion molecule, which contributes to cell-cell and cell-matrix adhesion,
cell growth, differentiation and trafficking [59]. Alternative splicing of the gene encoding for CD44
produces CD44 standard (CD44s) and CD44 variant (CD44v) forms numbered from v1 to v10, some of
which have been found to increase in tumor progression and metastasis [60,61]. It has been reported
that a CD44 isoform switches from a variant form to a standard form during the EMT process and that
CD44s has been correlated to a more mesenchymal phenotype, while the various CD44v forms are
related to increased cell adhesion [35,36,62–64].
Several studies have described dysregulated CD44 expression in the majority of human cancers,
including prostate cancer, and until now only few studies have explored the CD44 variants expressed
in PCa, providing controversial results, and the functional role of CD44s and CD44v is not fully
understood yet. For instance, CD44s together with an overexpression of all variants generated by
alternative splicing were detected in metastatic PCa patients, compared to the benign hypertrophy
controls [65], but it was also suggested that CD44s may exert an inhibitory effect on invasion and
migration, and that divergent effects could depend upon the specific tumor environment [66]. To the
best of our knowledge, this work is the first study investigating CD44s and variants in PCa cells grown
in 3D-cell cultures, and the first study analyzing CD44 in relation to EMT markers, contributing to the
comprehension of the expression of CD44 in PCa.
We detected higher CD44s mRNA levels in PC3 cells grown in 2D-monolayers compared to
DU145, suggesting that PC3 have a more mesenchymal phenotype compared to DU145 cells. This
gradient of EMT is consistent with higher N-cadherin mRNA levels in PC3 compared to DU145 cells.
EMT has been linked to stem cell phenotype [35–37], and EMT results in the acquisition of stem cell-like
properties, including slow proliferation and self-renewal potential [21,67,68]. Moreover, an important
role was described for N-cadherin, acting as a positive regulator of metastatic abilities of PCa cells
by modulating EMT and stemness properties via the receptor tyrosine kinase ErbB signaling [69].
Interestingly, 3D arrangement differently and significantly influenced PCa cell phenotype, inducing
an opposite effect, that is a significant up-regulation in PC3 and a down-regulation in DU145 cells
of CD44s. This result leads to the hypothesis that the 3D arrangement favors the acquisition of the
mesenchymal characteristics of PC3, while favoring a more epithelial-like phenotype in DU145 cells.
This idea was confirmed by the analysis of CD44s/CD44v6-7 and v9 ratios, which was useful
for understanding the possible functional role of CD44s and CD44v. Indeed, we found a significant
decrease of this ratio in DU145 3D-spheroids compared to 2D-monolayers.
The expression of CD44 variants on the surface of tumor cells was related to different PCa
characteristics and seems to be associated with invasive and metastatic behavior. Higher expression
levels of CD44v2 were detected in patients with a better survival rate, and a lower expression of
CD44v2 correlated with a 4 times greater risk of biochemical recurrence, suggesting CD44v2 has a
role as a prognostic marker for PCa [66]. CD44v6 is a marker able to differentiate epithelial from
mesenchymal prostate cancer cells [62,64]. It was also recently shown that CD44v6 expression is
necessary for anchorage independent growth and that high expression is associated with a poor
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outcome in prostate cancer patients [70]. Other studies in lung, colon, and breast cancer confirm that
higher CD44v6 expression is a negative prognostic indicator [71–73].
Here we have shown that also CD44 v2, v6, v7n and v9 resulted in differently expressed in PC3 and
DU145 cells. We detected higher expression in PC3 compared to DU145 monolayers, and a significant
up-regulation in PC3 3D aggregates compared to 2D-monolayers. According to the proposed roles
for CD44 variants, our data suggest that PC3 cells could exhibit a more mesenchymal phenotype
compared to DU145, and, very likely, a more malignant behavior. Conversely, 3D-arrangement elicits a
different CD44s/v ratio in PC3 and DU145 cells, allowing the detection of a different behavior. Since
CD44s and CD44v are related, respectively, to a more mesenchymal or epithelial phenotype, our results
suggest that DU145 cells have a more epithelial phenotype, compared to PC3 cells, consistent with the
stronger cell adhesion observed under the microscope.
The different phenotype, based on CD44 gene expression in PC3 and DU145 cells, was confirmed
by a different response to IL-4, a regulator of basal-like cells showing characteristics of tumor-initiating
cells by inducing expression of CD44. In fact, it was reported that IL-4 administration strongly induces
CD44 expression in PC3, but not in DU145 cells [74].
5. Conclusions
Our study provides a comprehensive analysis of the main epithelial and mesenchymal EMT
markers. Considered as a whole, our data could contribute to clarifying the expression of EMT
markers in PCa cells and the role of EMT in PCa progression, providing additional evidence that
PCa cells express EMT markers, and pointing to important differences in the phenotype of PCa cells
grown in 3D cell cultures. Although PC3 formed 3D aggregates containing cells loosely apposed
and their morphological characterization was not possible, PC3 grown in 3D aggregates were linked
by cell junctions; therefore, a cell-cell interaction induced by the 3D arrangement can be effective in
influencing cell phenotype, as confirmed by the molecular results, showing evident differences in PC3
2D-monolayers and 3D aggregates. Our data show that metastatic PC3 and DU145 PCa cells grown
in 3D cell cultures could better reveal their morpho-functional characteristics and a gradient of EMT,
representing a good experimental model useful for defining and recognizing cell phenotype in relation
to EMT and CD44 expression. Indeed, the important morphological and molecular differences in
cells grown in 2D-monolayers or in 3D cell cultures allow the identification of EMT-related markers
differently expressed in 2D and 3D cell cultures, in order to plan future studies focused on the analysis
of specific mechanisms underlying their roles in the complex EMT process. Moreover, they strongly
support the use of 3D-spheroids as a more suitable experimental model to mimic PCa cell behavior
in vitro, allowing us to distinguish and characterize different PCa cells, in order to understand and
predict their behavior, thus adding new knowledge to PCa biology and progression.
Since, to the best of our knowledge, this work is the first study investigating EMT markers and
CD44 variants in the same experimental conditions, and EMT has been linked to stem cell phenotype,
we feel that our results could contribute to understand PCa cells’ biology and behavior.
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